Ningbo Menovo Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002Y25
CNY
20.00
0.13 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
396.58
271.99
415.31
336.93
342.21
258.04
282.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
396.58
271.99
415.31
336.93
342.21
258.04
282.22
Raw Material Cost
276.33
198.06
287.39
226.86
269.96
176.55
224.66
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.64
10.35
27.58
5.25
8.25
7.20
8.14
Selling and Distribution Expenses
58.21
34.25
58.97
49.74
47.83
42.60
49.05
Other Expenses
0.41
0.23
0.51
1.43
1.58
0.61
1.95
Total Expenditure (Excl Depreciation)
357.26
244.93
379.01
296.18
341.84
232.49
301.40
Operating Profit (PBDIT) excl Other Income
39.300000000000004
27.1
36.3
40.8
0.4
25.6
-19.2
Other Income
12.91
10.71
18.93
17.81
-4.24
-3.95
-15.88
Operating Profit (PBDIT)
87.58
73.13
71.44
96.01
25.54
51.01
-35.10
Interest
18.64
10.35
27.58
5.25
8.25
7.20
8.14
Exceptional Items
-4.82
1.46
3.57
0.13
14.54
6.01
24.89
Gross Profit (PBDT)
120.25
73.93
127.93
110.07
72.25
81.49
57.57
Depreciation
35.36
35.36
38.96
38.96
29.41
29.41
31.34
Profit Before Tax
28.77
28.88
8.48
51.93
2.43
20.42
-49.69
Tax
1.52
5.69
-3.87
8.23
1.90
4.65
-4.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
27.83
21.22
3.56
44.31
4.90
14.04
-42.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
27.83
21.22
3.56
44.31
4.90
14.04
-42.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.06
1.97
4.78
2.17
0.56
1.73
-0.83
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.90
23.19
8.34
46.48
5.46
15.77
-43.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,245.80
2,219.26
2,192.74
2,171.10
2,115.87
2,110.74
2,096.25
Earnings per share (EPS)
0.1
0.1
0.02
0.21
0.01
0.07
-0.2
Diluted Earnings per share
0.1
0.1
0.02
0.21
0.01
0.07
-0.2
Operating Profit Margin (Excl OI)
9.91%
9.95%
3.26%
11.65%
0.11%
9.9%
-17.91%
Gross Profit Margin
16.17%
23.62%
11.42%
26.98%
9.3%
19.31%
-6.5%
PAT Margin
7.02%
7.8%
0.86%
13.15%
1.43%
5.44%
-15.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 45.81% vs -34.51% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 28.88% vs 179.52% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 19.71% vs 18.86% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 78.85% vs -62.32% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Ningbo Menovo Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
396.58
0
396.58
Other Operating Income
0.00
0.00
0.00
Total Operating income
396.58
0
396.58
Raw Material Cost
276.33
0
276.33
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
18.64
0
18.64
Selling and Distribution Expenses
58.21
0
58.21
Other Expenses
0.41
0.00
0.41
Total Expenditure (Excl Depreciation)
357.26
0
357.26
Operating Profit (PBDIT) excl Other Income
39.31
0.00
39.31
Other Income
12.91
0
12.91
Operating Profit (PBDIT)
87.58
0
87.58
Interest
18.64
0
18.64
Exceptional Items
-4.82
0
-4.82
Gross Profit (PBDT)
120.25
0
120.25
Depreciation
35.36
0
35.36
Profit Before Tax
28.77
0
28.77
Tax
1.52
0
1.52
Provisions and contingencies
0
0
0.00
Profit After Tax
27.83
0
27.83
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
27.83
0
27.83
Share in Profit of Associates
0
0
0.00
Minority Interest
2.06
0
2.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.90
0
29.90
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,245.80
0
2,245.80
Earnings per share (EPS)
0.10
0
0.10
Diluted Earnings per share
0.10
0
0.10
Operating Profit Margin (Excl OI)
9.91%
0%
0.00
9.91%
Gross Profit Margin
16.17%
0%
0.00
16.17%
PAT Margin
7.02%
0%
0.00
7.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 39.66 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 45.81% vs -34.51% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 15.90% vs 2.36% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.99 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 28.88% vs 179.52% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 443.64% vs 147.01% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.47 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 19.71% vs 18.86% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 150.67% vs -41.80% in Jun 2024

Quarterly - Interest
Interest 1.86 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 78.85% vs -62.32% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 126.83% vs -5.75% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.91%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024